Home | About the eMC | Help | Mobile
eMC - trusted, up to date and comprehensive information about medicines
Link to eMC medicine guides website
eMC homepage
Advanced search
Get Medicines Compendium UK app here

AstraZeneca UK Limited
Horizon Place, 600 Capability Green, Luton, Bedfordshire, LU1 3LU
Telephone: +44 (0)1582 836 000
Fax: +44 (0)1582 838 000
Medical Information Direct Line: +44 (0)1582 836 836
Medical Information e-mail: medical.informationuk@astrazeneca.com
Customer Care direct line: +44 (0)1582 837 837
Medical Information Fax: +44 (0)1582 838 003

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?
Patient Information Leaflet last updated on the eMC: 14/03/2012
PIL Zestril 2.5mg, 5mg,10mg, and 20mg tablets.

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 14/03/2012 and displayed until Current
Reasons for adding or updating:
  • Change to date of revision
  • Change to warnings or special precautions for use
  • Change to side-effects
  • Change to information about pregnancy or lactation
Updated on 17/02/2011 and displayed until 14/03/2012
Reasons for adding or updating:
  • Change to date of revision
  • Change of manufacturer
Updated on 30/09/2010 and displayed until 17/02/2011
Reasons for adding or updating:
  • Change/addition of instructions for reconstitution and/ or administration
  • Change to date of revision
  • Change to side-effects
  • Change to information about pregnancy or lactation
Updated on 10/03/2010 and displayed until 30/09/2010
Reasons for adding or updating:
  • Change to appearance of the medicine
  • Change to side-effects
  • Change to information about pregnancy or lactation
  • Change to name of manufacturer
Updated on 16/12/2009 and displayed until 10/03/2010
Reasons for adding or updating:
  • Change due to user-testing of patient information
Updated on 08/04/2009 and displayed until 16/12/2009
Reasons for adding or updating:
  • Change to side-effects
Updated on 21/11/2008 and displayed until 08/04/2009
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change to side-effects
  • Change to information about pregnancy or lactation
Updated on 05/06/2008 and displayed until 21/11/2008
Reasons for adding or updating:
  • Change to storage instructions
Updated on 29/06/2007 and displayed until 05/06/2008
Reasons for adding or updating:
  • Addition of Marketing Authorisation Holder
Updated on 18/08/2005 and displayed until 29/06/2007
Reasons for adding or updating:
  • Change to date of revision
  • Correction of spelling/typing errors
Updated on 19/07/2004 and displayed until 18/08/2005
Reasons for adding or updating:
  • Improved Electronic Presentation
Updated on 06/11/2002 and displayed until 19/07/2004
Reasons for adding or updating:
  • Update to PIL
Updated on 26/09/2002 and displayed until 06/11/2002
Reasons for adding or updating:
  • Update to PIL
Updated on 14/09/2000 and displayed until 26/09/2002
Reasons for adding or updating:
  • No reasons supplied

Active Ingredients/Generics

 
  lisinopril dihydrate